Justin C Brown1, Kathryn H Schmitz2. 1. All authors: Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. 2. All authors: Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. schmitz@mail.med.upenn.edu.
Abstract
PURPOSE:Survivors of breast cancer may experience deterioration of physical function. This is important because poor physical function may be associated with premature mortality, injurious falls, bone fracture, and disability. We conducted a post hoc analysis to explore the potential efficacy of slowly progressive weight lifting to reduce the incidence of physical function deterioration among survivors of breast cancer. METHODS:Between October 2005 and August 2008, we conducted a single-blind, 12-month, randomized controlled trial of twice-per-week slowly progressive weight lifting or standard care among 295 survivors of nonmetastatic breast cancer. In this post hoc analysis of data from the Physical Activity and Lymphedema Trial, we examined incident deterioration of physical function after 12 months, defined as a ≥ 10-point decrease in the physical function subscale of the Medical Outcomes Short-Form 36-item questionnaire. RESULTS: The proportion of participants who experienced incident physical function deterioration after 12 months was 16.3% (24/147) in the control group and 8.1% (12/148) in the weight lifting group (relative risk, 0.49; 95% CI, 0.25 to 0.96; P = .04). No serious or unexpected adverse events occurred that were related to weight lifting. CONCLUSION: Slowly progressive weight lifting compared with standard care reduced the incidence of physical function deterioration among survivors of breast cancer. These data are hypothesis generating. Future studies should directly compare the efficacy of weight lifting with other modalities of exercise, such as brisk walking, to appropriately inform the development of a confirmatory study designed to preserve physical function among survivors of breast cancer.
RCT Entities:
PURPOSE: Survivors of breast cancer may experience deterioration of physical function. This is important because poor physical function may be associated with premature mortality, injurious falls, bone fracture, and disability. We conducted a post hoc analysis to explore the potential efficacy of slowly progressive weight lifting to reduce the incidence of physical function deterioration among survivors of breast cancer. METHODS: Between October 2005 and August 2008, we conducted a single-blind, 12-month, randomized controlled trial of twice-per-week slowly progressive weight lifting or standard care among 295 survivors of nonmetastatic breast cancer. In this post hoc analysis of data from the Physical Activity and Lymphedema Trial, we examined incident deterioration of physical function after 12 months, defined as a ≥ 10-point decrease in the physical function subscale of the Medical Outcomes Short-Form 36-item questionnaire. RESULTS: The proportion of participants who experienced incident physical function deterioration after 12 months was 16.3% (24/147) in the control group and 8.1% (12/148) in the weight lifting group (relative risk, 0.49; 95% CI, 0.25 to 0.96; P = .04). No serious or unexpected adverse events occurred that were related to weight lifting. CONCLUSION: Slowly progressive weight lifting compared with standard care reduced the incidence of physical function deterioration among survivors of breast cancer. These data are hypothesis generating. Future studies should directly compare the efficacy of weight lifting with other modalities of exercise, such as brisk walking, to appropriately inform the development of a confirmatory study designed to preserve physical function among survivors of breast cancer.
Authors: Nazmus Saquib; John P Pierce; Juliann Saquib; Shirley W Flatt; Loki Natarajan; Wayne A Bardwell; Ruth E Patterson; Marcia L Stefanick; Cynthia A Thomson; Cheryl L Rock; Lovell A Jones; Ellen B Gold; Njeri Karanja; Barbara A Parker Journal: Psychooncology Date: 2011-03 Impact factor: 3.894
Authors: Marco Pahor; Jack M Guralnik; Walter T Ambrosius; Steven Blair; Denise E Bonds; Timothy S Church; Mark A Espeland; Roger A Fielding; Thomas M Gill; Erik J Groessl; Abby C King; Stephen B Kritchevsky; Todd M Manini; Mary M McDermott; Michael E Miller; Anne B Newman; W Jack Rejeski; Kaycee M Sink; Jeff D Williamson Journal: JAMA Date: 2014-06-18 Impact factor: 56.272
Authors: Lee W Jones; Kerry S Courneya; John R Mackey; Hyman B Muss; Edith N Pituskin; Jessica M Scott; Whitney E Hornsby; April D Coan; James E Herndon; Pamela S Douglas; Mark Haykowsky Journal: J Clin Oncol Date: 2012-05-21 Impact factor: 44.544
Authors: Dejana Braithwaite; William A Satariano; Barbara Sternfeld; Robert A Hiatt; Patricia A Ganz; Karla Kerlikowske; Dan H Moore; Martha L Slattery; Martin Tammemagi; Adrienne Castillo; Michelle Melisko; Laura Esserman; Erin K Weltzien; Bette J Caan Journal: J Natl Cancer Inst Date: 2010-09-22 Impact factor: 13.506
Authors: Patricia Rodrigues Lourenço Gomes; Ismael Forte Freitas Junior; Camila Buonani da Silva; Igor Conterato Gomes; Ana Paula Rodrigues Rocha; Afonso Shiguemi Inoue Salgado; Edna Maria do Carmo Journal: Rev Bras Ginecol Obstet Date: 2014-06
Authors: Carol E DeSantis; Chun Chieh Lin; Angela B Mariotto; Rebecca L Siegel; Kevin D Stein; Joan L Kramer; Rick Alteri; Anthony S Robbins; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2014-06-01 Impact factor: 508.702
Authors: Kathryn H Schmitz; Rehana L Ahmed; Andrea Troxel; Andrea Cheville; Rebecca Smith; Lorita Lewis-Grant; Cathy J Bryan; Catherine T Williams-Smith; Quincy P Greene Journal: N Engl J Med Date: 2009-08-13 Impact factor: 91.245
Authors: José Baselga; Nina Bhardwaj; Lewis C Cantley; Ronald DeMatteo; Raymond N DuBois; Margaret Foti; Susan M Gapstur; William C Hahn; Lee J Helman; Roy A Jensen; Electra D Paskett; Theodore S Lawrence; Stuart G Lutzker; Eva Szabo Journal: Clin Cancer Res Date: 2015-10-01 Impact factor: 12.531
Authors: Maria C Swartz; Zakkoyya H Lewis; Elizabeth J Lyons; Kristofer Jennings; Addie Middleton; Rachel R Deer; Demi Arnold; Kaitlin Dresser; Kenneth J Ottenbacher; James S Goodwin Journal: Arch Phys Med Rehabil Date: 2017-04-17 Impact factor: 3.966
Authors: Xiaochen Zhang; Ashley F Haggerty; Justin C Brown; Robert Giuntoli; Lilie Lin; Fiona Simpkins; Lorraine T Dean; Emily Ko; Mark A Morgan; Kathryn H Schmitz Journal: Gynecol Oncol Date: 2015-08-22 Impact factor: 5.482
Authors: Justin C Brown; Nevena Damjanov; Kerry S Courneya; Andrea B Troxel; Babette S Zemel; Michael R Rickels; Bonnie Ky; Andrew D Rhim; Anil K Rustgi; Kathryn H Schmitz Journal: Psychooncology Date: 2018-02-20 Impact factor: 3.894